Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
November 28 Product : Applied Therapeutics govorestat Indication : Galactosemia Three months after its original target action date, the FDA denied approval of Applied Therapeutics govorestat for the rare, genetic metabolic disorder galactosemia
Google and Gemini are trademarks of Google LLC
Personalized dosing, prescribed by your provider, dispensed by our clinical team
Health 114, 109110
At present, the therapeutic application and potential value of GLP-1RAs in diabetes has become a research hotspot
US$ 25.45
US$ 25.54
US$ 22.18
US$ 29.18
US$ 29.47
US$ 24.28
.png)
US$ 29.96
